证券研究报告 行业发展空间仍存，"好房子"市场前景广阔 ——地产杂谈系列之六十三 行业动态跟踪 地产行业 强于大市（维持） 证券分析师 杨 侃 投资咨询资格编号：S1060514080002 郑茜文 投资咨询资格编号：S1060520090003 2025年4月16日 请务必阅读正文后免责条款 投资要点 2025Q1楼市延续修复，整体市场好于预期 得益于政策催化和市场信心修复，2025Q1楼市整体好于预 期。从成交来看，30城新房成交同比降2%，较2024年全年 收窄19.4pct；10大城市二手房成交同比增长33%。从房价 走势来看，根据国家统计局数据，一二线城市新房价格环 比自2024年末以来逐步止跌回稳。 2025Q1新房成交降幅大幅收窄 -80% -60% -40% -20% 0% 20% 40% 0 2 4 6 8 10 12 14 16 2024/1 2024/4 2024/7 2024/10 2025/1 30城新房成交套数（万套） 同比 一二线城市新房价格逐步止跌回稳 -1.0% -0.8% -0.6% -0.4% -0.2% 0.0% 0.2% 0.4% 2024/1 2024/3 2024 ...

计算机 公 司 报 告 2025年04月16日 达梦数据(688692.SH) 2024年业绩表现良好，产品生态齐发力助推公司发展 推荐 ( 维持) 股价:347元 行情走势图 证券分析师 事项： 公司发布2024年年报。2024年，公司实现营业收入10.44亿元，同比增长 31.49%；实现归母净利润3.62亿元，同比增长22.22%；实现扣非归母净利润 3.41亿元，同比增长24.14%。 平安观点： 券 主要数据 行业 计算机 公司网址 www.dameng.com 大股东/持股 中国软件与技术服务股份有限公 司/18.91% 实际控制人 冯裕才 总股本(百万股) 76 流通A股(百万股) 15 流通B/H股(百万股) 总市值(亿元) 264 流通A股市值(亿元) 53 每股净资产(元) 42.60 资产负债率(%) 13.8 闫磊 投资咨询资格编号 S1060517070006 YANLEI511@pingan.com.cn 黄韦涵 投资咨询资格编号 S1060523070003 司 年 报 点 评 研 究 报 告 HUANGWEIHAN235@pingan.com.cn 研究助理 | 王佳一 | 一 ...

Investment Rating - The report maintains an "Outperform" rating for the real estate industry [1]. Core Insights - A new round of residential product iteration is underway, with "Fourth Generation Housing" leading the stabilization of prices. The concept of "Good Housing" has been included in the government work report for the first time in 2025, with specific construction standards defined by the Ministry of Housing and Urban-Rural Development [3][11]. - The potential for improvement in housing demand is accelerating, with an estimated average annual improvement demand of 590 million square meters from 2025 to 2030, corresponding to a market value of approximately 8 trillion yuan [3][38]. - Historical reviews of the automotive and smartphone industries indicate that product iterations can stabilize demand and improve profitability, suggesting similar trends may occur in the housing market [3][6]. Summary by Sections New Round of Residential Product Iteration - The introduction of "Fourth Generation Housing" is expected to stabilize prices and create a pricing benchmark in the market. This is crucial as the market has been experiencing a downward price spiral due to a lack of price anchors [3][27]. - The government has emphasized the need for high-quality housing, shifting the focus from mere availability to quality, safety, comfort, and sustainability [11][13]. Acceleration of Improvement Demand - The report estimates that the average annual improvement demand will increase by 60.8% to 941 million square meters from previous estimates, driven by the promotion of "Good Housing" [3][41]. - The current market conditions indicate that the top 30 real estate companies' sales only account for 27.5% of the projected improvement demand, highlighting significant growth potential for quality real estate firms [3][6]. Historical Review and Comparison - The report draws parallels between the housing market and the automotive/smartphone industries, suggesting that product iterations can lead to market restructuring and improved sales stability [3][6]. - The report notes that while the costs of Fourth Generation Housing may be higher, the potential for higher profit margins exists due to increased product value and shorter return cycles [3][6]. Investment Recommendations - The report suggests focusing on real estate companies with low historical burdens, optimized inventory structures, and strong product capabilities, such as China Overseas Land & Investment, China Resources Land, and Greentown China [3][6]. - It also recommends monitoring companies in related sectors, including brokerage and property management, which may benefit from the ongoing market changes [3][6].

公 司 报 告 建材 2025年04月16日 伟星新材(002372.SZ) 多因素致业绩下滑，收入端保持韧性 推荐 ( 维持) 股价:11.72元 相关研究报告 【平安证券】伟星新材（002372.SZ）*季报点评*业 绩仍具韧性，毛利率维持高位*推荐20241030 【平安证券】伟星新材（002372.SZ）*半年报点评* 投资收益减少拖累业绩，毛利率同比改善*推荐 20240825 证券分析师 事项： 公司公布2024年年报，全年实现营收62.7亿元，同比降1.8%，归母净利润9.5 亿元，同比降33.4%；其中四季度营收24.9亿元，同比降5.3%，归母净利润 3.3亿元，同比降41.1%。公司拟每10股派发现金红利5元（含税）。 平安观点： 报 点 评 研 究 报 告 行情走势图 郑南宏 投资咨询资格编号 S1060521120001 ZHENGNANHONG873@pingan.com.cn 杨侃 投资咨询资格编号 S1060514080002 BQV514 YANGKAN034@pingan.com.cn | | 2023A | 2024A | 2025E | 2026E | 2027E | | ...

其 他 报 告 2025年04月16日 晨会纪要 | 国内市场 | | 涨跌幅（%） | | | --- | --- | --- | --- | | 指数 | 收盘 | 1日 | 上周 | | 上证综合指数 | 3268 | 0.15 | -3.11 | | 深证成份指数 | 9858 | -0.27 | -5.13 | | 沪深300指数 | 3761 | 0.06 | -2.87 | | 创业板指数 | 1930 | -0.13 | -6.73 | | 上证国债指数 | 224 | 0.03 | 0.34 | | 上证基金指数 | 6727 | -0.17 | -3.08 | 资料来源:同花顺iFinD | 海外市场 | | 涨跌幅（%） | | | --- | --- | --- | --- | | 指数 | 收盘 | 1日 | 上周 | | 中国香港恒生指数 | 21466 | 0.23 | -8.47 | | 中国香港国企指数 | 7983 | 0.21 | -7.35 | | 中国台湾加权指数 | 19858 | 1.77 | -8.31 | | 道琼斯指数 | 40369 | -0.38 | 4 ...

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical sector [1]. Core Insights - The commercialization of nuclear medicine is accelerating, with significant growth in diagnostic nuclear drugs and the potential for domestic nuclear drugs to reach a commercialization inflection point [3][17]. - The report highlights the successful commercialization of Pluvicto and Lutathera, which are expected to generate substantial revenues, with Pluvicto projected to exceed $5 billion in peak sales [3][12]. - The report emphasizes the similarities between Radioligand Therapy (RDC) and Antibody-Drug Conjugates (ADC), suggesting that RDC could replicate the success of ADC in the market [3][22]. Summary by Sections Part 1: Overseas Nuclear Drug Rapid Growth, Domestic Commercialization Period - Overseas nuclear drugs are experiencing rapid commercialization, with Pluvicto achieving $1.392 billion in revenue in 2024, a 42% increase, and Lutathera generating $724 million, a 20% increase [3][12]. - The combined revenue from these two drugs for Novartis reached $2.116 billion, indicating the ongoing value realization of nuclear drugs [3][12]. - The report notes that the domestic nuclear drug market is set to expand significantly, with five new nuclear drugs approved since 2020, including Yttrium-90 microspheres from Yuan Da Pharmaceutical, which is expected to generate nearly HKD 500 million in revenue in 2024, a growth rate exceeding 140% [3][20]. Part 2: RDC Expected to Replicate ADC Success Path - RDC shares structural and mechanistic similarities with ADC, consisting of a targeting ligand, a linker, and a radioactive nuclide [3][22]. - The report outlines that both RDC and ADC have followed similar validation timelines, with ADC gaining market traction after the success of Enhertu, while RDC is now gaining attention following the success of Pluvicto [3][22]. - The market for new nuclear drugs is projected to reach approximately $4-5 billion in 2024, comparable to the ADC market size around 2021 [3][22]. Part 3: Domestic Nuclear Drug Pipeline Overview - The report details the current pipeline of domestic nuclear drugs, with three products in the NDA stage, including Novartis's PSMA diagnostic and therapeutic drugs [3][49]. - The leading targets in domestic research remain PSMA, FAP, and SSTR, with companies like Yuan Da Pharmaceutical and Xiantong Pharmaceutical leading in clinical project numbers [3][53]. - The anticipated approval of Novartis's two PSMA-targeted products in Q2 2025 is expected to further stimulate the domestic nuclear medicine market [3][20].

公 司 报 告 食品饮料 2025年04月15日 东鹏饮料(605499.SH) 强者恒强，Q1表现亮眼 推荐 ( 维持) 股价:267.58元 行情走势图 证券分析师 | 张晋溢 | 投资咨询资格编号 | | --- | --- | | | S1060521030001 | | | ZHANGJINYI112@pingan.com.cn | | 王萌 | 投资咨询资格编号 | | | S1060522030001 | WANGMENG917@pingan.com.cn 王星云 投资咨询资格编号 S1060523100001 事项： 公司发布2025年一季报，25Q1公司实现营业收入48.48亿元，同比增加 39.23%；实现归母净利润9.80亿元，同比增加47.62%。 平安观点： 证 券 研 究 报 告 wangxingyun937@pingan.com.cn 季 报 点 评 主要数据 行业 食品饮料 公司网址 www.szeastroc.com 大股东/持股 林木勤/49.74% 实际控制人 林木勤 总股本(百万股) 520 流通A股(百万股) 520 流通B/H股(百万股) 总市值(亿元) 1,391 ...

Investment Rating - The report maintains a "Recommended" rating for the company [1][4][12] Core Views - The company achieved a revenue of 23.882 billion yuan in 2024, representing a year-on-year growth of 7.24%, and a net profit attributable to shareholders of 678 million yuan, a significant increase of 299.90% [4][7] - The company is positioned among the top ten global outsourced packaging and testing companies, maintaining its industry ranking [7][8] - The semiconductor industry is entering an upward cycle, and the company is capitalizing on the recovery in communication terminals, achieving substantial growth in key areas such as SOC, WIFI, PMIC, and display drivers [7][8] Financial Summary - **Revenue and Profit Forecasts**: - 2024 Revenue: 23.882 billion yuan, 2025E: 26.728 billion yuan, 2026E: 29.658 billion yuan, 2027E: 32.682 billion yuan [6][9] - 2024 Net Profit: 678 million yuan, 2025E: 1.189 billion yuan, 2026E: 1.516 billion yuan, 2027E: 1.841 billion yuan [6][9] - **Profitability Ratios**: - Gross Margin: 14.8% in 2024, expected to increase to 15.7% by 2027 [10] - Net Margin: 2.8% in 2024, projected to reach 5.6% by 2027 [10] - Return on Equity (ROE): 4.6% in 2024, expected to grow to 9.9% by 2027 [10] - **Valuation Ratios**: - Price-to-Earnings (P/E) ratio: 57.8 in 2024, decreasing to 21.3 by 2027 [10] - Price-to-Book (P/B) ratio: 2.7 in 2024, expected to decline to 2.1 by 2027 [10] Market Position and Growth Drivers - The company has established significant partnerships with major clients in the mobile phone sector, achieving a 46% growth in mid-to-high-end mobile SOCs [7][8] - In the RF sector, collaboration with leading clients resulted in a 70% growth [7][8] - The company is expanding its presence in automotive applications, with a year-on-year increase of over 200% in automotive product performance [7][8]

Investment Rating - The industry investment rating is "Outperform the Market" (maintained) [1] Core Viewpoints - The report suggests that with the upcoming Politburo meeting in April and the introduction of "reciprocal tariffs," there may be an acceleration in the implementation of policies to stabilize the real estate market. The introduction of "good houses" in the government work report for 2025 and the definition of specific construction standards by the Ministry of Housing and Urban-Rural Development may lead to a new wave of demand for improved housing [3][4] - The report highlights potential investment opportunities in real estate companies with lighter historical burdens, optimized inventory structures, and strong product capabilities, such as China Overseas Development, China Resources Land, and Greentown China. It also suggests focusing on companies undergoing valuation recovery like Vanke A and Jindi Group [3][4] Policy Insights - The report indicates that the "reciprocal tariffs" policy has been introduced, and there is an expectation for further easing of real estate policies. This includes potential loosening of purchase restrictions in core cities, further interest rate cuts, and measures to expand housing demand [3][9] - The report notes that 17 housing-related policies were introduced in March 2025, primarily leaning towards easing measures, with a focus on stabilizing the market [8] Market Dynamics - In March, the average daily transaction volume of new homes in 50 key cities decreased by 1.1% year-on-year but increased by 52.5% month-on-month. The report anticipates gradual improvement in transactions as the supply of high-quality residential properties increases [3][22] - The average premium rate for land transactions in 100 cities reached a new high in nearly a year at 13.2%, indicating a concentration of land sales in core first- and second-tier cities [29][31] Company Performance - The report states that the sales amount of the top 100 real estate companies in March 2025 decreased by 12.1% year-on-year, with a cumulative decline of 7.3% for the first three months. The report emphasizes that future sales volume will largely depend on the supply of high-end quality residential properties [37][32] - The report highlights that the real estate sector's PE (TTM) is currently at 34.9 times, which is at the 90.2 percentile of the past five years, indicating a relatively high valuation [46]

息差降幅优于同业，资产质量夯实 银行 2025 年 4 月 15 日 北京银行(601169.SH) 推荐（维持） 股价：6.06 元 主要数据 | 行业 | 银行 | | --- | --- | | 公司网址 | www.bankof beijing.com.cn | | 大股东/持股 | ING BANK N.V./13.03% | | 实际控制人 | | | 总股本(百万股) | 21,143 | | 流通 A 股(百万股) | 21,143 | | 流通 B/H 股(百万股) | | | 总市值（亿元） | 1,281 | | 流通 A 股市值(亿元) | 1,281 | | 每股净资产(元) | 12.73 | | 资产负债率(%) | 91.5 | 行情走势图 相关研究报告 【平安证券】北京银行（601169.SH）*季报点评*业绩 表现符合预期，零售转型持续推进*推荐20241031 证券分析师 | 袁喆奇 | 投资咨询资格编号 | S1060520080003 | | --- | --- | --- | | YUANZHEQI052@pingan.com.cn | 许淼 | 投资咨询资格编号 ...